SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-167422
Filing Date
2022-06-03
Accepted
2022-06-03 17:05:04
Documents
12
Period of Report
2022-06-03
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K d365738d8k.htm   iXBRL 8-K 26415
  Complete submission text file 0001193125-22-167422.txt   152964

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA harp-20220603.xsd EX-101.SCH 2863
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE harp-20220603_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE harp-20220603_pre.xml EX-101.PRE 11712
6 EXTRACTED XBRL INSTANCE DOCUMENT d365738d8k_htm.xml XML 3486
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38800 | Film No.: 22995595
SIC: 2836 Biological Products, (No Diagnostic Substances)